Finisher 13SC is an innovative pesticide by Rudolf Group designed for efficient pest management. Combining Chlorfenapyr 10.5% and Spinosad 2.5%, this suspension concentrate (SC) formulation offers a robust solution for controlling thrips, fall armyworms, and other harmful worms. It is known for its unique mode of action and exceptional translaminar activity.
Farmers benefit from its rapid action, as pests show symptoms within minutes, significantly reducing plant damage. Being a biological insecticide, it provides long-duration control while remaining friendly to beneficial insects. Its low use rates make it cost-effective without compromising effectiveness.
Product Details:
Specification | Details |
---|---|
Active Ingredients | Chlorfenapyr 10.5% + Spinosad 2.5% |
Formulation | Suspension Concentrate (SC) |
Pack Sizes | 150 ML & 200 ML |
Target Pests | Thrips, Fall Armyworms, and Other Worms |
Category | Pesticides (Subcategory: Insecticides) |
Manufacturer | Rudolf Group (Better Chemistry) |
Key Benefits:
- Highly effective at low usage rates.
- Rapid cessation of pest damage after exposure.
- Provides extended pest control.
- Eco-friendly and safe for beneficial insects.
- Unique translaminar activity for superior performance.
FAQs:
What is it used for?
Finisher 13SC is used to control sucking pests like thrips, fall armyworms, and other worms affecting crops.
How does the product work?
It disrupts pests’ vital functions through its unique biological insecticidal action, leading to immediate symptoms and reduced plant damage.
Why should you choose this product?
Its dual-action formula, long-lasting effect, and safety for beneficial insects make it an excellent choice for pest management.
How to Use:
- Dilute as per recommended dose.
- Apply uniformly using a sprayer.
When can it be used?
Use during pest outbreaks or as a preventive measure for pest-prone seasons.
Approximate Coverage of Product:
A 150 ML bottle effectively covers an area depending on the infestation level and crop type.
Reviews
There are no reviews yet.